Publication | Closed Access
In vivo Monoamine Oxidase Inhibition Measured by Potentiation of Tryptamine Convulsions in Rats
21
Citations
0
References
1960
Year
Vivo Monoamine OxidaseProcaine AmidePsychotropic MedicationNeurotransmitterPharmacotherapyMedicinal ChemistryToxicologyNeurochemistryTryptamine ConvulsionsHealth SciencesPsychoactive DrugPsychiatryBehavioural PharmacologyBehavioral PharmacologyNeuropharmacologyNervous SystemDopaminePharmacologyNeurophysiologyPhysiologyInhibitory PotencyNeuroscienceCentral Nervous SystemMedicineDrug DiscoveryNeuropeptides
The in vivo monoamine oxidase (MAO) inhibitory potency of a number of drugs was tested by measuring their activity as potentiators of the convulsant effects of tryptamine. Effective MAO inhibitors. arranged in descending order of potency, included harmine (s.c.) tranylcypromine. SKF cis 385, d-PIH, dl-PIH, harmine (oral). RO-4-1018, nialamide, phenelzine, iproniazid, and isonicotinyl-PIH. Compounds ineffective as MAO inhibitors included diphenhydramine, tripelennamine, isoniazid, dihydroergotamine, mescaline, SKF 525-A, SKF 5-A, procaine, and procaine amide.